Nuvectis Pharma, Inc. NVCT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.13M-15.9% | $31.63M+70.7% | $35.44M+106% | $26.79M+47.9% | $29.86M+53.4% | ||
| $25.4M-15.8% | $31.71M+70.4% | $35.59M+106% | $27.01M+47.6% | $30.15M+52.9% | ||
| $25.4M-15.8% | $31.71M+70.4% | $35.59M+106% | $27.01M+47.6% | $30.15M+52.9% | ||
| $4.7M+56.9% | $6.27M+151% | $6.44M+185% | $4.98M+170% | $2.99M+70.1% | ||
| $11.18M+21.6% | $13.3M+49.5% | $11.58M+83.3% | $10.14M+75.6% | $9.19M+61.5% | ||
| $11.18M+21.6% | $13.3M+49.5% | $11.58M+83.3% | $10.14M+75.6% | $9.19M+61.5% | ||
| -$105.74M-34.6% | -$99.69M-36.1% | -$92.37M-37.9% | -$84.91M-35.1% | -$78.58M-34.5% | ||
| $14.22M-32.1% | $18.41M+89.6% | $24.01M+118% | $16.87M+34.7% | $20.95M+49.4% | ||
| $25.4M-15.8% | $31.71M+70.4% | $35.59M+106% | $27.01M+47.6% | $30.15M+52.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvectis Pharma, Inc.'s total assets?
- Nuvectis Pharma, Inc. (NVCT) holds $25.4M in total assets, down 15.8% year over year.
- How much cash does Nuvectis Pharma, Inc. have?
- Nuvectis Pharma, Inc. holds $25.1M in cash and equivalents.
- Can Nuvectis Pharma, Inc. cover its short-term obligations?
- Its current ratio is 2.27 — current assets exceed current liabilities.
- Where does Nuvectis Pharma, Inc.'s balance sheet data come from?
- Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.